PO.MCB04.02 · 分子与细胞生物学
脂肪酸暴露促进具有促肿瘤发生潜能的年龄相关性乳腺组织改变
Fatty acid exposure promotes age-related mammary tissue alterations with pro-tumorigenic potential
作者与单位 Authors & Affiliations
摘要 Abstract
中文摘要
引言。将未转化的乳腺细胞和乳腺微结构暴露于中链(MC)脂肪酸(FA)辛酸(OA)会诱导代谢向丝氨酸、一碳、甘氨酸和甲硫氨酸通路(SOG/甲硫氨酸)转变,增强表观遗传可塑性,增加活性氧(ROS),促进细胞存活并破坏细胞间通讯。类似地,衰老的乳腺以细胞间通讯破坏、表观遗传可塑性和ROS增加为特征。我们假设FA诱导的代谢重编程导致乳腺的生物学衰老,从而促成时序性衰老过程中观察到的促肿瘤发生改变。
方法。将MCF-10A细胞暴露于OA用于蛋白质组学分析。将暴露于±OA的乳腺微结构通过scRNAseq进行分析。将源自原代细胞的乳腺微结构和3D乳腺球包埋于Matrigel中,暴露于±OA 7天,对腔面和基底标志物、F-肌动蛋白和细胞核进行染色,并通过共聚焦显微镜成像以评估迁移/侵袭。用scRNAseq鉴定在含OA培养基中富集的迁移性细胞群。使用拉曼光谱(RS)表征正常乳腺组织中的脂质含量。
结果。OA处理诱导了先前在衰老和肿瘤发生背景下报道的变化,包括:(1)衰老相关基因(GDF15、MDK、PLIN2)上调(p<0.01),以及谱系标志物和MMP7(一种其下调促进乳腺上皮衰老的基因)下调(p<0.01);(2)衰老相关分泌表型(SASP)基因上调(p<0.01),包括AREG(重编程)和ANGPTL4(迁移);(3)通过AREG、GDF15和MDK的分泌性信号增加;以及(4)细胞外基质(ECM)-受体和细胞间相互作用减少。离体条件下,OA改变组织结构,破坏基底屏障并促进细胞迁移。BMYO1、LASP1和LHS1上皮亚型是OA培养基中的迁移细胞之一,并表达SASP、癌症(MYC、EGFR、SREBF1)、迁移(S100A4、NCAM1)、衰老和SOG/甲硫氨酸基因。FB1成纤维细胞在载体培养基中占主导,但OA有利于ECM解聚的FB2细胞。RS分析表明存在饱和与不饱和FA,并揭示存在如OA这样的MCFA,在绝经后组织中观察到更高的强度,支持了我们体外/离体发现的体内合理性。
结论。我们的数据支持一个模型,提示时序性和生物学衰老过程由于GDF15诱导的脂肪分解增加而增加游离FA的释放。FA的升高驱动乳腺重塑并加速腺体衰老。时序性和生物学衰老增加对乳腺癌的易感性。该模型提示了潜在的预防策略,如靶向GDF15和SOG/甲硫氨酸。
查看英文原文 English abstract
Introduction . Exposure of non-transformed breast cells and breast microstructures to the medium-chain (MC) fatty acid (FA) octanoic acid (OA) induces a metabolic shift toward the serine, one-carbon, glycine and methionine pathways (SOG/methionine), enhancing epigenetic plasticity, increasing reactive oxygen species (ROS), promoting cell survival and disrupting cell-cell communication. Similarly, the aged mammary gland is characterized by disrupted cell-cell communication, epigenetic plasticity and increased ROS. We hypothesize that FA-induced metabolic reprogramming leads to biological aging of the mammary gland, contributing to pro-tumorigenic alterations observed during chronologic aging.
Methods . MCF-10A cells were exposed to OA for proteomics. Breast microstructures exposed to ± OA were analyzed by scRNAseq. Breast microstructures and 3D mammary spheres derived from primary cells were embedded in Matrigel, exposed to ± OA for 7 days, stained for luminal and basal markers, F-actin, and nuclei, and imaged by confocal microscopy to assess migration/invasion. Migratory cell populations enriched in OA-containing media were identified with scRNAseq. Raman spectroscopy (RS) was used to characterize the lipid content in normal breast tissue.
Results . OA treatment induced changes previously reported in aging and tumorigenic contexts, including: (1) upregulation (p < 0.01) of aging-related genes ( GDF15, MDK, PLIN2 ), and downregulation (p < 0.01) of lineage markers and MMP7 , a gene whose downregulation promotes mammary epithelial aging; (2) upregulation (p < 0.01) of Senescence-Associated Secretory Phenotype (SASP) genes, including AREG (reprogramming) and ANGPTL4 (migration); (3) increased secreted signaling via AREG , GDF15 , and MDK; and (4) reduced extracelular matrix (ECM)-receptor and cell-cell interactions. Ex vivo , OA altered tissue architecture disrupting the basal barrier and promoting cellular migration. BMYO1, LASP1, and LHS1 epithelial subtypes were among the migratory cells in OA media and expressed SASP, cancer ( MYC , EGFR , SREBF1 ), migration ( S100A4 , NCAM1 ), aging and SOG/methionine genes. FB1 fibroblasts dominated in vehicle media, but OA favored ECM-disassembling FB2 cells. RS analysis demonstrates the presence of both saturated and unsaturated FAs and revealed the presence of MCFAs, such as OA, with higher intensities observed in the postmenopausal tissue supporting the in vivo plausibility of our in vitro/ex vivo findings .
Conclusions. Our data supports a model suggesting that chronological and biological aging processes increase the release of free FAs, due to elevated GDF15-induced lipolysis. The rise in FAs drives mammary gland remodeling and accelerates aging of the gland. Chronological and biological aging increase vulnerability to breast cancer. This model suggests potential preventive strategies such as targeting GDF15 and SOG/methionine.
利益披露 Disclosure
M. Bustamante Eduardo, None..
A. B. Islam, None..
C. W. McCloskey, None..
M. Zappia, None..
A. Z. Samuel, None..
M. V. Frolov, None..
R. Khokha, None..
R. Bhargava, None..
E. V. Benevolenskaya, None..
S. A. Khan, None..
S. E. Clare, None.